- Home
- KROS vs ITRN Comparison
KROS vs ITRN Comparison
Compare KROS & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ITRN
- Stock Information
- Founded
- KROS 2015
- ITRN 1994
- Country
- KROS United States
- ITRN Israel
- Employees
- KROS N/A
- ITRN N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ITRN Electronic Components
- Sector
- KROS Health Care
- ITRN Technology
- Exchange
- KROS Nasdaq
- ITRN Nasdaq
- Market Cap
- KROS 460.6M
- ITRN 623.7M
- IPO Year
- KROS 2020
- ITRN 2005
- Fundamental
- Price
- KROS $11.00
- ITRN $32.40
- Analyst Decision
- KROS Buy
- ITRN
- Analyst Count
- KROS 11
- ITRN 0
- Target Price
- KROS $45.33
- ITRN N/A
- AVG Volume (30 Days)
- KROS 2.1M
- ITRN 102.5K
- Earning Date
- KROS 02-26-2025
- ITRN 02-27-2025
- Dividend Yield
- KROS N/A
- ITRN 4.71%
- EPS Growth
- KROS N/A
- ITRN 15.25
- EPS
- KROS N/A
- ITRN 2.61
- Revenue
- KROS $651,000.00
- ITRN $331,182,000.00
- Revenue This Year
- KROS $303.27
- ITRN $7.15
- Revenue Next Year
- KROS N/A
- ITRN $8.63
- P/E Ratio
- KROS N/A
- ITRN $12.33
- Revenue Growth
- KROS 8037.50
- ITRN 4.43
- 52 Week Low
- KROS $9.78
- ITRN $24.12
- 52 Week High
- KROS $73.00
- ITRN $34.35
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- ITRN 49.28
- Support Level
- KROS $11.04
- ITRN $32.79
- Resistance Level
- KROS $11.99
- ITRN $33.71
- Average True Range (ATR)
- KROS 0.60
- ITRN 0.60
- MACD
- KROS 1.20
- ITRN -0.16
- Stochastic Oscillator
- KROS 43.99
- ITRN 12.20
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ITRN Ituran Location and Control Ltd.
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products. The Telematics services segment consists of regionally- based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal advanced locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others.